These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 15894656)
41. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204 [TBL] [Abstract][Full Text] [Related]
42. Update on screening breast MRI in high-risk women. Boetes C Magn Reson Imaging Clin N Am; 2010 May; 18(2):241-7, viii. PubMed ID: 20494309 [TBL] [Abstract][Full Text] [Related]
43. A review of mammary ductoscopy in breast cancer. Yamamoto D; Tanaka K Breast J; 2004; 10(4):295-7. PubMed ID: 15239786 [TBL] [Abstract][Full Text] [Related]
44. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). Kuhl CK J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663 [TBL] [Abstract][Full Text] [Related]
45. Cytology of ductal lavage fluid of the breast. Ljung BM; Chew KL; Moore DH; King EB Diagn Cytopathol; 2004 Mar; 30(3):143-50. PubMed ID: 14986293 [TBL] [Abstract][Full Text] [Related]
46. BMRI in early detection of breast cancer in patients with increased genetic risk: our preliminary results. Trecate G; Vergnaghi D; Bergonzi S; De Simone T; Costa C; Spatti GB; Pasini B; Musumeci R J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):125-30. PubMed ID: 12585666 [TBL] [Abstract][Full Text] [Related]
47. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Bhandare D; Nayar R; Bryk M; Hou N; Cohn R; Golewale N; Parker NP; Chatterton RT; Rademaker A; Khan SA Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2620-7. PubMed ID: 16284387 [TBL] [Abstract][Full Text] [Related]
48. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). Leach MO; Eeles RA; Turnbull LW; Dixon AK; Brown J; Hoff RJ; Coulthard A; Dixon JM; Easton DF; Evans DG; Gilbert FJ; Hawnaur J; Hayes C; Kessar P; Lakhani S; Liney G; Moss SM; Padhani AP; Pointon LJ; Sydenham M; Walker LG; Warren RM; Haites NE; Morrison P; Cole T; Rayter Z; Donaldson A; Shere M; Rankin J; Goudie D; Steel CM; Davidson R; Chu C; Ellis I; Mackay J; Hodgson SV; Homfray T; Douglas F; Quarrell OW; Eccles DM; Gilbert FG; Crothers G; Walker CP; Jones A; Slack N; Britton P; Sheppard DG; Walsh J; Whitehouse G; Teh W; Rankin S; Boggis C; Potterton J; McLean L; Gordon PA; Rubin C; J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):107-14. PubMed ID: 12585664 [TBL] [Abstract][Full Text] [Related]
49. Combined breast ductal lavage and ductal endoscopy for the evaluation of the high-risk breast: a feasibility study. Danforth DN; Abati A; Filie A; Prindiville SA; Palmieri D; Simon R; Ried T; Steeg PS J Surg Oncol; 2006 Dec; 94(7):555-64. PubMed ID: 17048242 [TBL] [Abstract][Full Text] [Related]
50. Ductal lavage and its histopathologic basis: a cautionary tale. Badve S Diagn Cytopathol; 2004 Mar; 30(3):166-71. PubMed ID: 14986296 [TBL] [Abstract][Full Text] [Related]
51. Clinical practice. Management of an inherited predisposition to breast cancer. Robson M; Offit K N Engl J Med; 2007 Jul; 357(2):154-62. PubMed ID: 17625127 [No Abstract] [Full Text] [Related]
52. Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice. Hodgson SV; Morrison PJ; Irving M Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):56-64. PubMed ID: 15264273 [TBL] [Abstract][Full Text] [Related]
53. Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience. Elmore L; Margenthaler JA Ann Surg Oncol; 2010 Oct; 17 Suppl 3():263-7. PubMed ID: 20853044 [TBL] [Abstract][Full Text] [Related]
54. Update on screening breast MRI in high-risk women. Boetes C Obstet Gynecol Clin North Am; 2011 Mar; 38(1):149-58, viii-ix. PubMed ID: 21419331 [TBL] [Abstract][Full Text] [Related]
56. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. Dooley WC; Ljung BM; Veronesi U; Cazzaniga M; Elledge RM; O'Shaughnessy JA; Kuerer HM; Hung DT; Khan SA; Phillips RF; Ganz PA; Euhus DM; Esserman LJ; Haffty BG; King BL; Kelley MC; Anderson MM; Schmit PJ; Clark RR; Kass FC; Anderson BO; Troyan SL; Arias RD; Quiring JN; Love SM; Page DL; King EB J Natl Cancer Inst; 2001 Nov; 93(21):1624-32. PubMed ID: 11698566 [TBL] [Abstract][Full Text] [Related]
57. MR imaging in screening women at increased risk for breast cancer. Boetes C; Stoutjesdijk M Magn Reson Imaging Clin N Am; 2001 May; 9(2):357-72, vii. PubMed ID: 11493425 [TBL] [Abstract][Full Text] [Related]
58. Assessment of utility of ductal lavage and ductoscopy in breast cancer-a retrospective analysis of mastectomy specimens. Badve S; Wiley E; Rodriguez N Mod Pathol; 2003 Mar; 16(3):206-9. PubMed ID: 12640099 [TBL] [Abstract][Full Text] [Related]
59. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851 [TBL] [Abstract][Full Text] [Related]
60. Breast cancer screening with MRI--what are the data for patients at high risk? Liberman L N Engl J Med; 2004 Jul; 351(5):497-500. PubMed ID: 15282358 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]